Tecan recently teamed up with Nature Medicine to host a symposium on the latest ground-breaking research into cancer diagnosis and treatment, from novel biomarkers to personalized vaccines and cell-based therapies. A select group of industry leaders and key experts in oncology came together for a two-day event in Boston, Massachusetts, to accelerate research and clinical discoveries through better partnering between industry and academia. This summit highlighted Tecan’s dedication to assembling leaders in cancer – along with technologists, vendors and solutions providers – so they can share knowledge and expertise, and work collaboratively to battle cancer.
Developing cancer drugs for clinical trials involves not only identifying and evaluating suitable agents, but also observing how they interact with the cocktail of other drugs in a cancer treatment regime. For the Telethon Kids Cancer Centre in Perth, Western Australia, increasing throughput and reducing assay volumes are essential to save money and time in the race to beat cancer.